Literature DB >> 22047989

The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.

Diana Edo-Matas1, Andrea Rachinger, Laurentia C Setiawan, Brigitte D Boeser-Nunnink, Angélique B van 't Wout, Philippe Lemey, Hanneke Schuitemaker.   

Abstract

To trace the evolutionary patterns underlying evolution of coreceptor use within a host, we studied an HIV-1 transmission pair involving a donor who exclusively harbored CCR5-using (R5) variants throughout his entire disease course and a recipient who developed CXCR4-using variants. Over time, R5 variants in the donor optimized coreceptor use, which was associated with an increased number of potential N-linked glycosylation sites (PNGS) and elevated V3 charge in the viral envelope. Interestingly, R5 variants that were transmitted to the recipient preserved the viral characteristics of this late stage genotype and phenotype. Following a selective sweep, CXCR4-using variants subsequently emerged in the recipient coinciding with a further increase in the number of PNGS and V3 charge in the envelope of R5 viruses. Although described in a single transmission pair, the transmission and subsequent persistence of R5 variants with late stage characteristics demonstrate the potential for coreceptor use adaptation at the population level.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22047989     DOI: 10.1016/j.virol.2011.10.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Genetic signatures of HIV-1 envelope-mediated bystander apoptosis.

Authors:  Anjali Joshi; Raphael T C Lee; Jonathan Mohl; Melina Sedano; Wei Xin Khong; Oon Tek Ng; Sebastian Maurer-Stroh; Himanshu Garg
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

2.  Parameters Influencing Baseline HIV-1 Genotypic Tropism Testing Related to Clinical Outcome in Patients on Maraviroc.

Authors:  Saleta Sierra; J Nikolai Dybowski; Alejandro Pironti; Dominik Heider; Lisa Güney; Alex Thielen; Stefan Reuter; Stefan Esser; Gerd Fätkenheuer; Thomas Lengauer; Daniel Hoffmann; Herbert Pfister; Björn Jensen; Rolf Kaiser
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

3.  Statistical correlation of nonconservative substitutions of HIV gp41 variable amino acid residues with the R5X4 HIV-1 phenotype.

Authors:  Elena Pacheco-Martínez; Evangelina Figueroa-Medina; Carlos Villarreal; Germinal Cocho; José L Medina-Franco; Oscar Méndez-Lucio; Leonor Huerta
Journal:  Virol J       Date:  2016-02-16       Impact factor: 4.099

4.  Selective Bottlenecks Shape Evolutionary Pathways Taken during Mammalian Adaptation of a 1918-like Avian Influenza Virus.

Authors:  Louise H Moncla; Gongxun Zhong; Chase W Nelson; Jorge M Dinis; James Mutschler; Austin L Hughes; Tokiko Watanabe; Yoshihiro Kawaoka; Thomas C Friedrich
Journal:  Cell Host Microbe       Date:  2016-02-10       Impact factor: 21.023

5.  HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.

Authors:  Karen P Coss; Snezana Vasiljevic; Laura K Pritchard; Stefanie A Krumm; Molly Glaze; Sharon Madzorera; Penny L Moore; Max Crispin; Katie J Doores
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

6.  Protein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism.

Authors:  Xiaowei Jiang; Felix Feyertag; David L Robertson
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 7.  Emergence of Nanotechnology to Fight HIV Sexual Transmission: The Trip of G2-S16 Polyanionic Carbosilane Dendrimer to Possible Pre-Clinical Trials.

Authors:  Ignacio Relaño-Rodríguez; Maria Ángeles Muñoz-Fernández
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.